Kirill V Odarenko

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 30, 2025
Deciphering the Role of ADAMTS6 in the Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Cells.

Kirill V Odarenko, Anastasiya M Matveeva, Grigory A Stepanov

|Oct 16, 2025
Transcriptomic-Driven Drug Repurposing Reveals SP600125 as a Promising Drug Candidate for the Treatment of Glial-Mesenchymal Transition in Glioblastoma.

Kirill V Odarenko, Marina A Zenkova, Andrey V Markov

|Jan 25, 2025
Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural-Mesenchymal Transition.

Andrey V Markov, Arseny D Moralev, Kirill V Odarenko

|Dec 23, 2023
The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies.

Kirill V Odarenko, Marina A Zenkova, Andrey V Markov

|Oct 28, 2023
Soloxolone Methyl Reduces the Stimulatory Effect of Leptin on the Aggressive Phenotype of Murine Neuro2a Neuroblastoma Cells via the MAPK/ERK1/2 Pathway.

Kirill V Odarenko, Oksana V Salomatina, Ivan V Chernikov

Pageof 1

Frequent Collaborators

5 joint publications

Andrey V Markov

4 joint publications

Marina A Zenkova

1 joint publications

Arseny D Moralev

1 joint publications

Grigory A Stepanov